LexaGene
LexaGene Files for Chapter 7 Bankruptcy
The company has ceased operations and laid off staff, while a bankruptcy trustee will liquidate its assets and distribute any proceeds.
In Brief This Week: OpGen, MDxHealth, Dante Genomics, More
New items for the week of Oct. 24, 2022.
LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats
The RT-PCR system was developed for veterinary diagnostic and food safety applications but is being tested for human pathogens under the cooperative R&D agreement.
LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch
The Beverly, Massachusetts-based firm noted that all revenue from its MiQLab was generated from US customers.
Sep 9, 2020
LexaGene Closes C$13.3M Funding Round
Oct 29, 2019
LexaGene Closes C$6.6M Financing Round
Mar 29, 2019
LexaGene Closes C$2.8M Private Placement
Mar 13, 2019